Supporting files for 'Development of a new health-related quality of life measure for people living with diabetes who experience hypoglycaemia: The Hypo-RESOLVE QoL'

Supporting files for the development of a novel patient-reported outcome measure for assesing the health-related quality of life impacts of hypoglycaemia in people living with diabetes: the Hypo-RESOLVE QoL. These files are designed to accompany a manuscript submitted for publication entitled: 'Development of a new health-related quality of life measure for people living with diabetes who experience hypoglycaemia: The Hypo-RESOLVE QoL'.

This research is part of the international Hypo-RESOLVE project, funded by the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777460. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and T1DExchange, JDRF, IDF, HCT.

A protocol for the work has been published online: Carlton et al. (2023), https://doi.org/10.1111/dme.15007

The research received ethical approval from the UK National Health Service (NHS REC reference: 20/NI/0048)

支持开发新型患者报告结局量表，用于评估糖尿病患者低血糖对健康相关生活质量的影响：Hypo-RESOLVE QoL。这些文件旨在配合一篇投稿的学术论文，该论文题目为：《为经历低血糖的糖尿病患者开发新的健康相关生活质量评估量表：Hypo-RESOLVE QoL》。本研究属于国际Hypo-RESOLVE项目的一部分，该项目由创新药物倡议2联合执行体（JU）资助，资助协议编号为No 777460。JU得到欧盟“地平线2020”研究和创新计划的资助，以及EFPIA和T1DExchange、JDRF、IDF、HCT的支持。一项关于研究方案的工作已经在线发表：Carlton等人（2023年），https://doi.org/10.1111/dme.15007。该研究获得了英国国家医疗服务体系（NHS）伦理审查委员会的批准（NHS REC参考编号：20/NI/0048）。